90645 Hemophilus influenza b vaccine (Hib), HbOC conjugate (4 dose schedule), for intramuscular use

Hemophilus Influenza b Vaccine (Hib), HbOC Conjugate (4 Dose Schedule), for Intramuscular Use

Name of the Procedure:

• Common Name: Hib Vaccine
• Technical/Military Term: Hemophilus influenzae type b, Haemophilus b Conjugate Vaccine (Hib), HbOC Conjugate

Summary

The Hib vaccine is an injection given to protect against infections caused by the Haemophilus influenzae type b bacteria. This vaccine is typically administered in a series of four doses through an intramuscular injection to ensure optimal immunity.

Purpose

The Hib vaccine is designed to prevent illnesses such as meningitis, pneumonia, and epiglottitis caused by Haemophilus influenzae type b bacteria. These infections can be serious and sometimes life-threatening, particularly in young children.

Indications

• Infants and young children typically receive this vaccine.
• Individuals receiving the vaccine should be under 5 years of age, particularly those aged 2 months to 4 years.
• Recommended for children who have not been fully immunized by their age milestones.

Preparation

• Parents should bring their child’s immunization record to the appointment.
• No specific fasting or medication adjustments are generally required.
• Screening for possible contraindications or allergies may be done.

Procedure Description

1. The healthcare provider will clean the injection site with an antiseptic wipe.
2. Using a sterile syringe, the provider will administer the vaccine intramuscularly, usually in the thigh or upper arm.
3. A bandage may be applied to the injection site.
4. The patient is observed for a short period to monitor for any immediate adverse reactions.

Duration

• The administration of each dose typically takes just a few minutes.
• The entire four-dose schedule is generally completed over a span of several months, starting at 2 months of age.

Setting

• The Hib vaccine is administered in outpatient clinics, pediatrician's offices, and vaccination centers.

Personnel

• Administered by trained healthcare professionals, such as nurses or pediatricians.

Risks and Complications

• Common: Pain, redness, or swelling at the injection site, mild fever.
• Rare: Allergic reactions, such as hives, difficulty breathing, and swelling of the face or throat. Emergency care might be needed for severe reactions.

Benefits

• Provides effective protection against serious illnesses caused by Haemophilus influenzae type b bacteria.
• Benefits are typically realized within a few weeks after completing the vaccine series.

Recovery

• Post-vaccination, children can usually return to normal activities immediately.
• Minor soreness at the injection site may persist for a couple of days.
• Follow-up appointments will be scheduled to complete the vaccine series.

Alternatives

• No true alternatives to the vaccine for immunization against Hib.
• The only other option is avoiding vaccination which increases the risk of severe Hib infection.

Patient Experience

• The injection might cause brief discomfort.
• Some mild side effects like slight fever or irritability may be managed with over-the-counter pain relievers, as advised by the healthcare provider.
• Comfort measures such as cuddling the child, distraction techniques, and breastfeeding can be effective.